Morgan Stanley’s Sophiris Bio, Inc. SPHS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,512
| Closed | -$2K | – | 6964 |
|
|
2019
Q4 | $2K | Sell |
4,512
-488
| -10% | -$222 | ﹤0.01% | 6540 |
|
|
2019
Q3 | $3K | Hold |
5,000
| – | – | ﹤0.01% | 6459 |
|
|
2019
Q2 | $4K | Hold |
5,000
| – | – | ﹤0.01% | 6388 |
|
|
2019
Q1 | $5K | Hold |
5,000
| – | – | ﹤0.01% | 6347 |
|
|
2018
Q4 | $4K | Hold |
5,000
| – | – | ﹤0.01% | 6360 |
|
|
2018
Q3 | $14K | Buy |
5,000
+2,000
| +67% | +$5.69K | ﹤0.01% | 6241 |
|
|
2018
Q2 | $8K | Sell |
3,000
-2,000
| -40% | -$5.94K | ﹤0.01% | 6364 |
|
|
2018
Q1 | $10K | Hold |
5,000
| – | – | ﹤0.01% | 6275 |
|
|
2017
Q4 | $11K | Hold |
5,000
| – | – | ﹤0.01% | 6208 |
|
|
2017
Q3 | $11K | Buy |
5,000
+2,000
| +67% | +$4.14K | ﹤0.01% | 6163 |
|
|
2017
Q2 | $7K | Hold |
3,000
| – | – | ﹤0.01% | 6314 |
|
|
2017
Q1 | $8K | Hold |
3,000
| – | – | ﹤0.01% | 6286 |
|
|
2016
Q4 | $8K | Buy |
3,000
+300
| +11% | +$849 | ﹤0.01% | 6216 |
|
|
2016
Q3 | $8K | Buy |
2,700
+2,475
| +1,100% | +$9.31K | ﹤0.01% | 6170 |
|
|
2016
Q2 | $0 | Sell |
225
-199,705
| -100% | -$276K | ﹤0.01% | 6983 |
|
|
2016
Q1 | $288K | Sell |
199,930
-18,879
| -9% | -$33.3K | ﹤0.01% | 4772 |
|
|
2015
Q4 | $389K | Buy |
218,809
+165,174
| +308% | +$244K | ﹤0.01% | 4706 |
|
|
2015
Q3 | $46K | Buy |
53,635
+41,106
| +328% | +$35.8K | ﹤0.01% | 5768 |
|
|
2015
Q2 | $10K | Buy |
12,529
+12,501
| +44,646% | +$10.6K | ﹤0.01% | 6308 |
|
|
2015
Q1 | $0 | Hold |
28
| – | – | ﹤0.01% | 6963 |
|
|
2014
Q4 | $0 | Hold |
28
| – | – | ﹤0.01% | 6993 |
|
|
2014
Q3 | $0 | Sell |
28
-199
| -88% | -$560 | ﹤0.01% | 6933 |
|
|
2014
Q2 | $0 | Hold |
227
| – | – | ﹤0.01% | 6859 |
|
|
2014
Q1 | $1K | Buy |
227
+27
| +14% | +$106 | ﹤0.01% | 6452 |
|
|
2013
Q4 | $1K | Buy |
+200
| New | +$846 | ﹤0.01% | 6346 |
|
Other funds holding SPHS
Morgan Stanley's SPHS Position: Q1 2020 in Review
Morgan Stanley sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 4,512 shares — an estimated $2K sold.
Morgan Stanley first reported a position in SPHS in Q4 2013 and held it in 25 quarters. The position peaked at $389K in Q4 2015. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.
- Morgan Stanley reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
- Morgan Stanley sold 4,512 Sophiris Bio, Inc. shares in Q1 2020, an estimated $2K.
- Morgan Stanley first reported a position in Sophiris Bio, Inc. in Q4 2013 and held it in 25 quarters.
- Morgan Stanley's Sophiris Bio, Inc. position peaked at $389K in Q4 2015.
- 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.
Based on Morgan Stanley's 13F filing for Q1 2020, filed 15 May 2020.